Given the structural similarities between GAC and GLS2, it might be expected that GLS2 would undergo a similar structural transition, although GLS2 can in some cancers exhibit the opposite effects from GAC by acting as a tumor suppressor rather than a promoter raising the possibility that it might exhibit distinct structural features. This evidence concerns the gene GLS2 and cancer.